Deciphera Pharmaceuticals, LLC — Form D/A
Deciphera Pharmaceuticals, LLC of WALTHAM, MA, a company, filed a Form D amendment with the SEC on 2016-07-14. The offering totals $90.6M, of which $90.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-07-14
- Form: D/A
- Accession: 0001654151-16-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $90.6M
- Amount sold: $90.6M
- Investors: 5
- Date of first sale: 2015-09-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-248413
Issuer
- Name: Deciphera Pharmaceuticals, LLC
- CIK: 0001654151
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 500 Totten Pond Road, WALTHAM, MA, 02451
- Phone: 781-209-6400
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Michael Taylor | Director | Westlake Village, CA |
| Daniel F Flynn, Ph.D. | Executive Officer | Waltham, MA |
| Thomas F Kelly | Executive Officer | Waltham, MA |
| Oliver F Rosen, M.D. | Executive Officer | Waltham, MA |
| Michael Taylor | Executive Officer | Westlake Village, CA |
| Edward J Benz, Jr. | Director | Aspen, CO |
| Michael A Ross | Director | Gaithersburg, MD |
| Patricia L Allen | Director | San Diego, CA |
| James A Bristol, Ph.D. | Director | San Diego, CA |
| John A Martin | Director | Rolling Hills Estates, CA |
| Oliver L Rosen, M.D. | Executive Officer | Waltham, MA |
| Thomas L Kelly | Executive Officer | Waltham, MA |
| Daniel L Flynn, Ph.D. | Executive Officer | Waltham, MA |
| Dennis A Walsh | Director | Waltham, MA |
| Michael D Taylor, Ph.D. | Director | Waltham, MA |
| Michael D Taylor, Ph.D. | Executive Officer | Waltham, MA |
| Liam A Ratcliffe, M.D., Ph.D. | Director | Waltham, MA |
| Christopher J Morl | Executive Officer | Boulder, CO |
Other filings by this issuer (2)
More